| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |